Sales Support
U.S.:+1-415-871-0703
U.K.:+44-203-289-4040
AUS.: +61-2-4786-0457
INDIA:+91-848-285-0837
Contact Us
We have an updated report [Version - 2023] available. Kindly sign up to get the sample of the report.
Healthcare and Pharmaceuticals industry

Sexually Transmitted Diseases Std Testing Market 2020 By Manufacturers, Regions, Type, And Application, Forecast To 2026

  • Purchase Options

 

Impact Analysis of Covid-19

The complete version of the REPORT will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

Summary

The global Sexually Transmitted Diseases Std Testing Market is expected to witness a CAGR of xx% over the forecast period 2020-2026 and is expected to reach US$ xx million in 2026, from US$ xx million in 2019. 

The Sexually Transmitted Diseases Std Testing Market report highlights product development and growth strategies such as merger and acquisition adopted by market players along with SWOT Analysis, PEST and Porter’s Five Forces analyses of the Sexually Transmitted Diseases Std Testing Market, which highlight the strengths, weaknesses, opportunities, and commination of key companies. Moreover, the report offers two distinct market forecasts, one from the perspective of the producer and another from that of the consumer.

The various contributors involved in the value chain of the product include manufacturers, suppliers, distributors, intermediaries, and customers.

The Key Manufacturers covered in this Report:-

  • ROCHE HOLDINGS
  • BIOMERIEUX
  • HOLOGIC
  • BECTON DICKINSON
  • ORASURE
  • DANAHER
  • AFFYMETRIX
  • ABBOTT LABORATORIES
  • BIO-RAD LABORATORIES
  • DIASORIN

By the Product Type, the market is primarily segmented into:

  • Chlamydia
  • Syphilis
  • Gonorrhea
  • Herpes Simplex Virus
  • Human Papilloma Virus
  • Human Immunodeficiency Virus
  • Others
  • Market segment by Application, split into
  • Laboratory Testing
  • Point of Care (POC) Testing

By Applications, the market is segmented into:

  • Laboratory Testing
  • Point of Care (POC) Testing

The Report covers the following Regions:

  • North America
    • United States
    • Canada
    • Mexico
  • Asia Pacific
    • China
    • Japan
    • South Korea
    • India
    • Australia
    • Indonesia
    • Thailand
    • Malaysia
    • Philippines
    • Vietnam
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Central & South America
    • Brazil
  • Middle East & Africa
    • Turkey
    • GCC Countries
    • Egypt
    • South Africa

Objective of the Sexually Transmitted Diseases Std Testing Market Report:

  • To assess the size of the market by value and volume
  • Analyze the Sexually Transmitted Diseases Std Testing Market in terms of regions and major countries
  • Highlight recent developments and trends in the market
  • Offer perceptive data regarding major market players in terms of key developments, strategies, and product portfolio
  • Determine share of the Sexually Transmitted Diseases Std Testing Market in terms of various segments such as by product type, application, and end-user
  • Offer accurate projection of the market for the forecast period using state-of –the-art tools and the current primary and secondary research approaches
  • Discuss major factors that impact growth of the Sexually Transmitted Diseases Std Testing Market

The Sexually Transmitted Diseases Std Testing Market engages the readers with all pivotal approaches to understand their position in the industry based on revenue or sales growth. The report efficiently evaluates the Sexually Transmitted Diseases Std Testing Market from various dimensions to deliver an end-product that is informative, elaborate, and accurate and includes detailed market segmentation, regional analysis, and competition in the market. The information in the report is backed by annual company reports, financial reports, press releases, regulatory databases, government documents, and statistical databases.

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders:

  • Material suppliers/wholesalers
  • Market Distributors/traders
  • Regulatory bodies
  • Research organizations, and consulting firms
  • Commercial research & developments (R&D)
  • Trade associations and industry bodies
  • Importers and exporters
  • End-use industries

Available Customizations:

Custom research is one of the most crucial components of the business strategy that helps an organization gain insight into specific business sector, aligned with its specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Sexually Transmitted Diseases (STD) Testing Revenue
1.4 Market Analysis by Type
1.4.1 Global Sexually Transmitted Diseases (STD) Testing Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Chlamydia
1.4.3 Syphilis
1.4.4 Gonorrhea
1.4.5 Herpes Simplex Virus
1.4.6 Human Papilloma Virus
1.4.7 Human Immunodeficiency Virus
1.4.8 Others
1.5 Market by Application
1.5.1 Global Sexually Transmitted Diseases (STD) Testing Market Share by Application: 2020 VS 2026
1.5.2 Laboratory Testing
1.5.3 Point of Care (POC) Testing
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends by Regions
2.1 Sexually Transmitted Diseases (STD) Testing Market Perspective (2015-2026)
2.2 Sexually Transmitted Diseases (STD) Testing Growth Trends by Regions
2.2.1 Sexually Transmitted Diseases (STD) Testing Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Sexually Transmitted Diseases (STD) Testing Historic Market Share by Regions (2015-2020)
2.2.3 Sexually Transmitted Diseases (STD) Testing Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porters Five Forces Analysis
2.3.5 Sexually Transmitted Diseases (STD) Testing Market Growth Strategy
2.3.6 Primary Interviews with Key Sexually Transmitted Diseases (STD) Testing Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Sexually Transmitted Diseases (STD) Testing Players by Market Size
3.1.1 Global Top Sexually Transmitted Diseases (STD) Testing Players by Revenue (2015-2020)
3.1.2 Global Sexually Transmitted Diseases (STD) Testing Revenue Market Share by Players (2015-2020)
3.1.3 Global Sexually Transmitted Diseases (STD) Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Sexually Transmitted Diseases (STD) Testing Market Concentration Ratio
3.2.1 Global Sexually Transmitted Diseases (STD) Testing Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Sexually Transmitted Diseases (STD) Testing Revenue in 2019
3.3 Sexually Transmitted Diseases (STD) Testing Key Players Head office and Area Served
3.4 Key Players Sexually Transmitted Diseases (STD) Testing Product Solution and Service
3.5 Date of Enter into Sexually Transmitted Diseases (STD) Testing Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)
4.1 Global Sexually Transmitted Diseases (STD) Testing Historic Market Size by Type (2015-2020)
4.2 Global Sexually Transmitted Diseases (STD) Testing Forecasted Market Size by Type (2021-2026)

5 Sexually Transmitted Diseases (STD) Testing Breakdown Data by Application (2015-2026)
5.1 Global Sexually Transmitted Diseases (STD) Testing Market Size by Application (2015-2020)
5.2 Global Sexually Transmitted Diseases (STD) Testing Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Sexually Transmitted Diseases (STD) Testing Market Size (2015-2020)
6.2 Sexually Transmitted Diseases (STD) Testing Key Players in North America (2019-2020)
6.3 North America Sexually Transmitted Diseases (STD) Testing Market Size by Type (2015-2020)
6.4 North America Sexually Transmitted Diseases (STD) Testing Market Size by Application (2015-2020)

7 Europe
7.1 Europe Sexually Transmitted Diseases (STD) Testing Market Size (2015-2020)
7.2 Sexually Transmitted Diseases (STD) Testing Key Players in Europe (2019-2020)
7.3 Europe Sexually Transmitted Diseases (STD) Testing Market Size by Type (2015-2020)
7.4 Europe Sexually Transmitted Diseases (STD) Testing Market Size by Application (2015-2020)

8 China
8.1 China Sexually Transmitted Diseases (STD) Testing Market Size (2015-2020)
8.2 Sexually Transmitted Diseases (STD) Testing Key Players in China (2019-2020)
8.3 China Sexually Transmitted Diseases (STD) Testing Market Size by Type (2015-2020)
8.4 China Sexually Transmitted Diseases (STD) Testing Market Size by Application (2015-2020)

9 Japan
9.1 Japan Sexually Transmitted Diseases (STD) Testing Market Size (2015-2020)
9.2 Sexually Transmitted Diseases (STD) Testing Key Players in Japan (2019-2020)
9.3 Japan Sexually Transmitted Diseases (STD) Testing Market Size by Type (2015-2020)
9.4 Japan Sexually Transmitted Diseases (STD) Testing Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Sexually Transmitted Diseases (STD) Testing Market Size (2015-2020)
10.2 Sexually Transmitted Diseases (STD) Testing Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Sexually Transmitted Diseases (STD) Testing Market Size by Type (2015-2020)
10.4 Southeast Asia Sexually Transmitted Diseases (STD) Testing Market Size by Application (2015-2020)

11 India
11.1 India Sexually Transmitted Diseases (STD) Testing Market Size (2015-2020)
11.2 Sexually Transmitted Diseases (STD) Testing Key Players in India (2019-2020)
11.3 India Sexually Transmitted Diseases (STD) Testing Market Size by Type (2015-2020)
11.4 India Sexually Transmitted Diseases (STD) Testing Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Sexually Transmitted Diseases (STD) Testing Market Size (2015-2020)
12.2 Sexually Transmitted Diseases (STD) Testing Key Players in Central & South America (2019-2020)
12.3 Central & South America Sexually Transmitted Diseases (STD) Testing Market Size by Type (2015-2020)
12.4 Central & South America Sexually Transmitted Diseases (STD) Testing Market Size by Application (2015-2020)

13Key Players Profiles
13.1 ROCHE HOLDINGS
13.1.1 ROCHE HOLDINGS Company Details
13.1.2 ROCHE HOLDINGS Business Overview and Its Total Revenue
13.1.3 ROCHE HOLDINGS Sexually Transmitted Diseases (STD) Testing Introduction
13.1.4 ROCHE HOLDINGS Revenue in Sexually Transmitted Diseases (STD) Testing Business (2015-2020))
13.1.5 ROCHE HOLDINGS Recent Development
13.2 BIOMERIEUX
13.2.1 BIOMERIEUX Company Details
13.2.2 BIOMERIEUX Business Overview and Its Total Revenue
13.2.3 BIOMERIEUX Sexually Transmitted Diseases (STD) Testing Introduction
13.2.4 BIOMERIEUX Revenue in Sexually Transmitted Diseases (STD) Testing Business (2015-2020)
13.2.5 BIOMERIEUX Recent Development
13.3 HOLOGIC
13.3.1 HOLOGIC Company Details
13.3.2 HOLOGIC Business Overview and Its Total Revenue
13.3.3 HOLOGIC Sexually Transmitted Diseases (STD) Testing Introduction
13.3.4 HOLOGIC Revenue in Sexually Transmitted Diseases (STD) Testing Business (2015-2020)
13.3.5 HOLOGIC Recent Development
13.4 BECTON DICKINSON
13.4.1 BECTON DICKINSON Company Details
13.4.2 BECTON DICKINSON Business Overview and Its Total Revenue
13.4.3 BECTON DICKINSON Sexually Transmitted Diseases (STD) Testing Introduction
13.4.4 BECTON DICKINSON Revenue in Sexually Transmitted Diseases (STD) Testing Business (2015-2020)
13.4.5 BECTON DICKINSON Recent Development
13.5 ORASURE
13.5.1 ORASURE Company Details
13.5.2 ORASURE Business Overview and Its Total Revenue
13.5.3 ORASURE Sexually Transmitted Diseases (STD) Testing Introduction
13.5.4 ORASURE Revenue in Sexually Transmitted Diseases (STD) Testing Business (2015-2020)
13.5.5 ORASURE Recent Development
13.6 DANAHER
13.6.1 DANAHER Company Details
13.6.2 DANAHER Business Overview and Its Total Revenue
13.6.3 DANAHER Sexually Transmitted Diseases (STD) Testing Introduction
13.6.4 DANAHER Revenue in Sexually Transmitted Diseases (STD) Testing Business (2015-2020)
13.6.5 DANAHER Recent Development
13.7 AFFYMETRIX
13.7.1 AFFYMETRIX Company Details
13.7.2 AFFYMETRIX Business Overview and Its Total Revenue
13.7.3 AFFYMETRIX Sexually Transmitted Diseases (STD) Testing Introduction
13.7.4 AFFYMETRIX Revenue in Sexually Transmitted Diseases (STD) Testing Business (2015-2020)
13.7.5 AFFYMETRIX Recent Development
13.8 ABBOTT LABORATORIES
13.8.1 ABBOTT LABORATORIES Company Details
13.8.2 ABBOTT LABORATORIES Business Overview and Its Total Revenue
13.8.3 ABBOTT LABORATORIES Sexually Transmitted Diseases (STD) Testing Introduction
13.8.4 ABBOTT LABORATORIES Revenue in Sexually Transmitted Diseases (STD) Testing Business (2015-2020)
13.8.5 ABBOTT LABORATORIES Recent Development
13.9 BIO-RAD LABORATORIES
13.9.1 BIO-RAD LABORATORIES Company Details
13.9.2 BIO-RAD LABORATORIES Business Overview and Its Total Revenue
13.9.3 BIO-RAD LABORATORIES Sexually Transmitted Diseases (STD) Testing Introduction
13.9.4 BIO-RAD LABORATORIES Revenue in Sexually Transmitted Diseases (STD) Testing Business (2015-2020)
13.9.5 BIO-RAD LABORATORIES Recent Development
13.10 DIASORIN
13.10.1 DIASORIN Company Details
13.10.2 DIASORIN Business Overview and Its Total Revenue
13.10.3 DIASORIN Sexually Transmitted Diseases (STD) Testing Introduction
13.10.4 DIASORIN Revenue in Sexually Transmitted Diseases (STD) Testing Business (2015-2020)
13.10.5 DIASORIN Recent Development

14Analyst's Viewpoints/Conclusions

15Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List of Table
List of Tables

Table 1. Sexually Transmitted Diseases (STD) Testing Key Market Segments
Table 2. Key Players Covered: Ranking by Sexually Transmitted Diseases (STD) Testing Revenue
Table 3. Ranking of Global Top Sexually Transmitted Diseases (STD) Testing Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Sexually Transmitted Diseases (STD) Testing Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Chlamydia
Table 6. Key Players of Syphilis
Table 7. Key Players of Gonorrhea
Table 8. Key Players of Herpes Simplex Virus
Table 9. Key Players of Human Papilloma Virus
Table 10. Key Players of Human Immunodeficiency Virus
Table 11. Key Players of Others
Table 12. Global Sexually Transmitted Diseases (STD) Testing Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 13. Global Sexually Transmitted Diseases (STD) Testing Market Size by Regions (US$ Million): 2020 VS 2026
Table 14. Global Sexually Transmitted Diseases (STD) Testing Market Size by Regions (2015-2020) (US$ Million)
Table 15. Global Sexually Transmitted Diseases (STD) Testing Market Share by Regions (2015-2020)
Table 16. Global Sexually Transmitted Diseases (STD) Testing Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 17. Global Sexually Transmitted Diseases (STD) Testing Market Share by Regions (2021-2026)
Table 18. Market Top Trends
Table 19. Key Drivers: Impact Analysis
Table 20. Key Challenges
Table 21. Sexually Transmitted Diseases (STD) Testing Market Growth Strategy
Table 22. Main Points Interviewed from Key Sexually Transmitted Diseases (STD) Testing Players
Table 23. Global Sexually Transmitted Diseases (STD) Testing Revenue by Players (2015-2020) (Million US$)
Table 24. Global Sexually Transmitted Diseases (STD) Testing Market Share by Players (2015-2020)
Table 25. Global Top Sexually Transmitted Diseases (STD) Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Sexually Transmitted Diseases (STD) Testing as of 2019)
Table 26. Global Sexually Transmitted Diseases (STD) Testing by Players Market Concentration Ratio (CR5 and HHI)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Sexually Transmitted Diseases (STD) Testing Product Solution and Service
Table 29. Date of Enter into Sexually Transmitted Diseases (STD) Testing Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Sexually Transmitted Diseases (STD) Testing Market Size by Type (2015-2020) (Million US$)
Table 32. Global Sexually Transmitted Diseases (STD) Testing Market Size Share by Type (2015-2020)
Table 33. Global Sexually Transmitted Diseases (STD) Testing Revenue Market Share by Type (2021-2026)
Table 34. Global Sexually Transmitted Diseases (STD) Testing Market Size Share by Application (2015-2020)
Table 35. Global Sexually Transmitted Diseases (STD) Testing Market Size by Application (2015-2020) (Million US$)
Table 36. Global Sexually Transmitted Diseases (STD) Testing Market Size Share by Application (2021-2026)
Table 37. North America Key Players Sexually Transmitted Diseases (STD) Testing Revenue (2019-2020) (Million US$)
Table 38. North America Key Players Sexually Transmitted Diseases (STD) Testing Market Share (2019-2020)
Table 39. North America Sexually Transmitted Diseases (STD) Testing Market Size by Type (2015-2020) (Million US$)
Table 40. North America Sexually Transmitted Diseases (STD) Testing Market Share by Type (2015-2020)
Table 41. North America Sexually Transmitted Diseases (STD) Testing Market Size by Application (2015-2020) (Million US$)
Table 42. North America Sexually Transmitted Diseases (STD) Testing Market Share by Application (2015-2020)
Table 43. Europe Key Players Sexually Transmitted Diseases (STD) Testing Revenue (2019-2020) (Million US$)
Table 44. Europe Key Players Sexually Transmitted Diseases (STD) Testing Market Share (2019-2020)
Table 45. Europe Sexually Transmitted Diseases (STD) Testing Market Size by Type (2015-2020) (Million US$)
Table 46. Europe Sexually Transmitted Diseases (STD) Testing Market Share by Type (2015-2020)
Table 47. Europe Sexually Transmitted Diseases (STD) Testing Market Size by Application (2015-2020) (Million US$)
Table 48. Europe Sexually Transmitted Diseases (STD) Testing Market Share by Application (2015-2020)
Table 49. China Key Players Sexually Transmitted Diseases (STD) Testing Revenue (2019-2020) (Million US$)
Table 50. China Key Players Sexually Transmitted Diseases (STD) Testing Market Share (2019-2020)
Table 51. China Sexually Transmitted Diseases (STD) Testing Market Size by Type (2015-2020) (Million US$)
Table 52. China Sexually Transmitted Diseases (STD) Testing Market Share by Type (2015-2020)
Table 53. China Sexually Transmitted Diseases (STD) Testing Market Size by Application (2015-2020) (Million US$)
Table 54. China Sexually Transmitted Diseases (STD) Testing Market Share by Application (2015-2020)
Table 55. Japan Key Players Sexually Transmitted Diseases (STD) Testing Revenue (2019-2020) (Million US$)
Table 56. Japan Key Players Sexually Transmitted Diseases (STD) Testing Market Share (2019-2020)
Table 57. Japan Sexually Transmitted Diseases (STD) Testing Market Size by Type (2015-2020) (Million US$)
Table 58. Japan Sexually Transmitted Diseases (STD) Testing Market Share by Type (2015-2020)
Table 59. Japan Sexually Transmitted Diseases (STD) Testing Market Size by Application (2015-2020) (Million US$)
Table 60. Japan Sexually Transmitted Diseases (STD) Testing Market Share by Application (2015-2020)
Table 61. Southeast Asia Key Players Sexually Transmitted Diseases (STD) Testing Revenue (2019-2020) (Million US$)
Table 62. Southeast Asia Key Players Sexually Transmitted Diseases (STD) Testing Market Share (2019-2020)
Table 63. Southeast Asia Sexually Transmitted Diseases (STD) Testing Market Size by Type (2015-2020) (Million US$)
Table 64. Southeast Asia Sexually Transmitted Diseases (STD) Testing Market Share by Type (2015-2020)
Table 65. Southeast Asia Sexually Transmitted Diseases (STD) Testing Market Size by Application (2015-2020) (Million US$)
Table 66. Southeast Asia Sexually Transmitted Diseases (STD) Testing Market Share by Application (2015-2020)
Table 67. India Key Players Sexually Transmitted Diseases (STD) Testing Revenue (2019-2020) (Million US$)
Table 68. India Key Players Sexually Transmitted Diseases (STD) Testing Market Share (2019-2020)
Table 69. India Sexually Transmitted Diseases (STD) Testing Market Size by Type (2015-2020) (Million US$)
Table 70. India Sexually Transmitted Diseases (STD) Testing Market Share by Type (2015-2020)
Table 71. India Sexually Transmitted Diseases (STD) Testing Market Size by Application (2015-2020) (Million US$)
Table 72. India Sexually Transmitted Diseases (STD) Testing Market Share by Application (2015-2020)
Table 73. Central & South America Key Players Sexually Transmitted Diseases (STD) Testing Revenue (2019-2020) (Million US$)
Table 74. Central & South America Key Players Sexually Transmitted Diseases (STD) Testing Market Share (2019-2020)
Table 75. Central & South America Sexually Transmitted Diseases (STD) Testing Market Size by Type (2015-2020) (Million US$)
Table 76. Central & South America Sexually Transmitted Diseases (STD) Testing Market Share by Type (2015-2020)
Table 77. Central & South America Sexually Transmitted Diseases (STD) Testing Market Size by Application (2015-2020) (Million US$)
Table 78. Central & South America Sexually Transmitted Diseases (STD) Testing Market Share by Application (2015-2020)
Table 79. ROCHE HOLDINGS Company Details
Table 80. ROCHE HOLDINGS Business Overview
Table 81. ROCHE HOLDINGS Product
Table 82. ROCHE HOLDINGS Revenue in Sexually Transmitted Diseases (STD) Testing Business (2015-2020) (Million US$)
Table 83. ROCHE HOLDINGS Recent Development
Table 84. BIOMERIEUX Company Details
Table 85. BIOMERIEUX Business Overview
Table 86. BIOMERIEUX Product
Table 87. BIOMERIEUX Revenue in Sexually Transmitted Diseases (STD) Testing Business (2015-2020) (Million US$)
Table 88. BIOMERIEUX Recent Development
Table 89. HOLOGIC Company Details
Table 90. HOLOGIC Business Overview
Table 91. HOLOGIC Product
Table 92. HOLOGIC Revenue in Sexually Transmitted Diseases (STD) Testing Business (2015-2020) (Million US$)
Table 93. HOLOGIC Recent Development
Table 94. BECTON DICKINSON Company Details
Table 95. BECTON DICKINSON Business Overview
Table 96. BECTON DICKINSON Product
Table 97. BECTON DICKINSON Revenue in Sexually Transmitted Diseases (STD) Testing Business (2015-2020) (Million US$)
Table 98. BECTON DICKINSON Recent Development
Table 99. ORASURE Company Details
Table 100. ORASURE Business Overview
Table 101. ORASURE Product
Table 102. ORASURE Revenue in Sexually Transmitted Diseases (STD) Testing Business (2015-2020) (Million US$)
Table 103. ORASURE Recent Development
Table 104. DANAHER Company Details
Table 105. DANAHER Business Overview
Table 106. DANAHER Product
Table 107. DANAHER Revenue in Sexually Transmitted Diseases (STD) Testing Business (2015-2020) (Million US$)
Table 108. DANAHER Recent Development
Table 109. AFFYMETRIX Company Details
Table 110. AFFYMETRIX Business Overview
Table 111. AFFYMETRIX Product
Table 112. AFFYMETRIX Revenue in Sexually Transmitted Diseases (STD) Testing Business (2015-2020) (Million US$)
Table 113. AFFYMETRIX Recent Development
Table 114. ABBOTT LABORATORIES Business Overview
Table 115. ABBOTT LABORATORIES Product
Table 116. ABBOTT LABORATORIES Company Details
Table 117. ABBOTT LABORATORIES Revenue in Sexually Transmitted Diseases (STD) Testing Business (2015-2020) (Million US$)
Table 118. ABBOTT LABORATORIES Recent Development
Table 119. BIO-RAD LABORATORIES Company Details
Table 120. BIO-RAD LABORATORIES Business Overview
Table 121. BIO-RAD LABORATORIES Product
Table 122. BIO-RAD LABORATORIES Revenue in Sexually Transmitted Diseases (STD) Testing Business (2015-2020) (Million US$)
Table 123. BIO-RAD LABORATORIES Recent Development
Table 124. DIASORIN Company Details
Table 125. DIASORIN Business Overview
Table 126. DIASORIN Product
Table 127. DIASORIN Revenue in Sexually Transmitted Diseases (STD) Testing Business (2015-2020) (Million US$)
Table 128. DIASORIN Recent Development
Table 129. Research Programs/Design for This Report
Table 130. Key Data Information from Secondary Sources
Table 131. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Sexually Transmitted Diseases (STD) Testing Market Share by Type: 2020 VS 2026
Figure 2. Chlamydia Features
Figure 3. Syphilis Features
Figure 4. Gonorrhea Features
Figure 5. Herpes Simplex Virus Features
Figure 6. Human Papilloma Virus Features
Figure 7. Human Immunodeficiency Virus Features
Figure 8. Others Features
Figure 9. Global Sexually Transmitted Diseases (STD) Testing Market Share by Application: 2020 VS 2026
Figure 10. Laboratory Testing Case Studies
Figure 11. Point of Care (POC) Testing Case Studies
Figure 12. Sexually Transmitted Diseases (STD) Testing Report Years Considered
Figure 13. Global Sexually Transmitted Diseases (STD) Testing Market Size YoY Growth 2015-2026 (US$ Million)
Figure 14. Global Sexually Transmitted Diseases (STD) Testing Market Share by Regions: 2020 VS 2026
Figure 15. Global Sexually Transmitted Diseases (STD) Testing Market Share by Regions (2021-2026)
Figure 16. Porter's Five Forces Analysis
Figure 17. Global Sexually Transmitted Diseases (STD) Testing Market Share by Players in 2019
Figure 18. Global Top Sexually Transmitted Diseases (STD) Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Sexually Transmitted Diseases (STD) Testing as of 2019
Figure 19. The Top 10 and 5 Players Market Share by Sexually Transmitted Diseases (STD) Testing Revenue in 2019
Figure 20. North America Sexually Transmitted Diseases (STD) Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Europe Sexually Transmitted Diseases (STD) Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. China Sexually Transmitted Diseases (STD) Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Japan Sexually Transmitted Diseases (STD) Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Southeast Asia Sexually Transmitted Diseases (STD) Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. India Sexually Transmitted Diseases (STD) Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Central & South America Sexually Transmitted Diseases (STD) Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. ROCHE HOLDINGS Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. ROCHE HOLDINGS Revenue Growth Rate in Sexually Transmitted Diseases (STD) Testing Business (2015-2020)
Figure 29. BIOMERIEUX Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. BIOMERIEUX Revenue Growth Rate in Sexually Transmitted Diseases (STD) Testing Business (2015-2020)
Figure 31. HOLOGIC Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. HOLOGIC Revenue Growth Rate in Sexually Transmitted Diseases (STD) Testing Business (2015-2020)
Figure 33. BECTON DICKINSON Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. BECTON DICKINSON Revenue Growth Rate in Sexually Transmitted Diseases (STD) Testing Business (2015-2020)
Figure 35. ORASURE Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. ORASURE Revenue Growth Rate in Sexually Transmitted Diseases (STD) Testing Business (2015-2020)
Figure 37. DANAHER Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. DANAHER Revenue Growth Rate in Sexually Transmitted Diseases (STD) Testing Business (2015-2020)
Figure 39. AFFYMETRIX Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. AFFYMETRIX Revenue Growth Rate in Sexually Transmitted Diseases (STD) Testing Business (2015-2020)
Figure 41. ABBOTT LABORATORIES Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. ABBOTT LABORATORIES Revenue Growth Rate in Sexually Transmitted Diseases (STD) Testing Business (2015-2020)
Figure 43. BIO-RAD LABORATORIES Total Revenue (US$ Million): 2019 Compared with 2018
Figure 44. BIO-RAD LABORATORIES Revenue Growth Rate in Sexually Transmitted Diseases (STD) Testing Business (2015-2020)
Figure 45. DIASORIN Total Revenue (US$ Million): 2019 Compared with 2018
Figure 46. DIASORIN Revenue Growth Rate in Sexually Transmitted Diseases (STD) Testing Business (2015-2020)
Figure 47. Bottom-up and Top-down Approaches for This Report
Figure 48. Data Triangulation
Figure 49. Key Executives Interviewed
 

  • Purchase Options

  • Happy To Assist You

Frequently Asked Questions

The report efficiently evaluates the market from various dimensions to deliver an end-product that is informative, elaborate, and accurate and includes detailed market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast. The market was valued at xx Million US$ in 2019, and is expected to grow at a CAGR of xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the industry in terms of Value (US$ Mn) and Volume (Mn Units).
Market is segmented by Product Types, Drug Class, Indication, Applications, Services Types, End-users, Distribution channel, and Regions.
The report presents the current market size, and market forecast, market opportunities, key drivers and restraints, pipeline Analysis, incidence rate, epidemiology analysis, prevalence rate, regulatory scenario, industry trend, PESTLE analysis, PORTER’s analysis, new product approvals/launch, promotion and marketing initiatives, pricing analysis, export-import analysis, trade analysis, competitive landscape which help businesses in decision making. The analysis data is based on current and historical market trends which help in investment related decisions.
Custom research is crucial components of the business strategy which helps any organization to gain insight into specific business sector, aligned with specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.

Get In Touch

In search of customized market research solution? We are here to help you. Contact us.

Contact us